Literature DB >> 22428172

The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy.

Elegast Monbaliu1, Els Ortibus, Jos De Cat, Bernard Dan, Lieve Heyrman, Peter Prinzie, Paul De Cock, Hilde Feys.   

Abstract

AIM: The aim of this study was to examine the reliability and validity of the Dyskinesia Impairment Scale (DIS). The DIS consists of two subscales: dystonia and choreoathetosis. It measures both phenomena in dyskinetic cerebral palsy (CP).
METHOD: Twenty-five participants with dyskinetic CP (17 males; eight females; age range 5–22y; mean age 13y 6mo; SD 5y 4mo), recruited from special schools for children with motor disorders, were included. Exclusion criteria were changes in muscle relaxant medication within the previous 3 months, orthopaedic or neurosurgical interventions within the previous year, and spinal fusion. Interrater reliability was verified by two independent raters. For interrater reliability, intraclass correlation coefficients were assessed. Standard error of measurement, the minimal detectable difference, and Cronbach’s alpha for internal consistency were determined. For concurrent validity of the DIS dystonia subscale, the Barry–Albright Dystonia Scale was administered.
RESULTS: The intraclass correlation coefficient for the total DIS score and the two subscales ranged between 0.91 and 0.98 for interrater reliability. The reliability of the choreoathetosis subscale was found to be higher than that of the dystonia subscale. The standard error of the measurement and minimal detectable difference values were adequate. Cronbach’s alpha values ranged from 0.89 to 0.93. Pearson’s correlation between the dystonia subscale and Barry–Albright Dystonia Scale was 0.84 (p<0.001).
INTERPRETATION: Good to excellent reliability and validity were found for the DIS. The DIS may be promising for increasing insights into the natural history of dyskinetic CP and evaluating interventions. Future research on the responsiveness of the DIS is warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22428172     DOI: 10.1111/j.1469-8749.2011.04209.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  14 in total

Review 1.  A Critical Evaluation of Current Concepts in Cerebral Palsy.

Authors:  Joline E Brandenburg; Matthew J Fogarty; Gary C Sieck
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Neuroradiological and neurophysiological characteristics of patients with dyskinetic cerebral palsy.

Authors:  Byung-Hyun Park; Sung-Hee Park; Jeong-Hwan Seo; Myoung-Hwan Ko; Gyung-Ho Chung
Journal:  Ann Rehabil Med       Date:  2014-04-29

3.  Home-Based Measurements of Dystonia in Cerebral Palsy Using Smartphone-Coupled Inertial Sensor Technology and Machine Learning: A Proof-of-Concept Study.

Authors:  Dylan den Hartog; Marjolein M van der Krogt; Sven van der Burg; Ignazio Aleo; Johannes Gijsbers; Laura A Bonouvrié; Jaap Harlaar; Annemieke I Buizer; Helga Haberfehlner
Journal:  Sensors (Basel)       Date:  2022-06-09       Impact factor: 3.847

4.  Using Decision Trees to Support Classifiers' Decision-Making about Activity Limitation of Cerebral Palsy Footballers.

Authors:  José M Sarabia; Alba Roldan; Matías Henríquez; Raul Reina
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

Review 5.  Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy.

Authors:  Vito Pavone; Gianluca Testa; Domenico A Restivo; Luca Cannavò; Giuseppe Condorelli; Nicola M Portinaro; Giuseppe Sessa
Journal:  Front Pharmacol       Date:  2016-02-19       Impact factor: 5.810

6.  Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit.

Authors:  Kirsty Stewart; Gavin Hutana; Megan Kentish
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

7.  PREDICT-CP: study protocol of implementation of comprehensive surveillance to predict outcomes for school-aged children with cerebral palsy.

Authors:  Roslyn N Boyd; Peter Sw Davies; Jenny Ziviani; Stewart Trost; Lee Barber; Robert Ware; Stephen Rose; Koa Whittingham; Leanne Sakzewski; Kristie Bell; Christopher Carty; Steven Obst; Katherine Benfer; Sarah Reedman; Priya Edwards; Megan Kentish; Lisa Copeland; Kelly Weir; Camilla Davenport; Denise Brooks; Alan Coulthard; Rebecca Pelekanos; Andrea Guzzetta; Simona Fiori; Meredith Wynter; Christine Finn; Andrea Burgess; Kym Morris; John Walsh; Owen Lloyd; Jennifer A Whitty; Paul A Scuffham
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

Review 8.  The Symptomatic Treatment of Acquired Dystonia: A Systematic Review.

Authors:  Corina N A M van den Heuvel; Marina A J Tijssen; Bart P C van de Warrenburg; Cathérine C S Delnooz
Journal:  Mov Disord Clin Pract       Date:  2016-08-03

Review 9.  Trihexyphenidyl for dystonia in cerebral palsy.

Authors:  Adrienne R Harvey; Louise B Baker; Dinah Susan Reddihough; Adam Scheinberg; Katrina Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15

10.  Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial.

Authors:  Laura A Bonouvrié; Jules G Becher; Johannes S H Vles; Karin Boeschoten; Dan Soudant; Vincent de Groot; Willem J R van Ouwerkerk; Rob L M Strijers; Elisabeth Foncke; Joke Geytenbeek; Peter M van de Ven; Onno Teernstra; R Jeroen Vermeulen
Journal:  BMC Pediatr       Date:  2013-10-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.